What: Seed grants for pilot studies that encourage clinical-translational research
For: Up to $50,000 in direct costs
Who: full-time UB faculty or with affiliated Buffalo Translational Consortium institution
Due: Letter of Intent by 2:00 PM, Oct. 20, 2016 (Full applications are by invitation only and due Dec. 20)
Send to: CTSA-Pilot-Studies@buffalo.edu
The Buffalo Translational Consortium (BTC) looks for pilot studies that:
We focus on projects that:
Priority consideration goes to those applications that:
Research that addresses healthcare disparities can be implemented across all levels of analysis, including examples such as understanding genetic or epigenetic effects on healthcare disparities, through biological and neurobiological influences on healthcare disparities, individual differences in response to drugs that may explain differential health benefits to new or commonly used pharmacological interventions, or developing unique programs that address healthcare disparities or underrepresented populations in Western New York.
In addition, proposals that will advance ways in which creativity and innovation can be stimulated, fostered and augmented in the design and conduct of clinical-translational research will be entertained.
The CTSA and institutional funds support these pilot studies. They are intended for one year's duration, from April/May 2017 through March/April 2018.
Budget: Maximum of $50,000 in direct costs.
Not allowed:
You must 1) be a full-time faculty member at UB or affiliated Buffalo Translational Consortium institution; and 2) agree, if called upon, to serve as a reviewer of proposals submitted for this or future rounds of pilot studies funding.
Application for Pilot Studies funding involves a two-tiered process:
Submission of Letters of Intent - Two-page limit:
Due Date: Oct. 20, 2016, no later than 2:00 PM.
Submit as a PDF; use Arial, 11- point font, single-spaced text; 0.5-inch margins.
Email to: CTSA-Pilot-Studies@buffalo.edu
Subject Line: LOI CTSA Pilot Studies Fall 2016.
All submitters will be notified in early November with a decision as to whether or not their proposals have been chosen to move forward to the second tier of application submission. Submission of full applications by invitation only.
Applications will be rated using the following criteria:
No clinical trials beyond phase IIA will be supported by this CTSA program
Project Description: Arial, 11-point font, single-spaced text; 0.5-inch margins
Template:
NOTE: Appendices, other than funding agency reviews, are not allowed and will not be reviewed if attached.
**Assemble all documents into a single PDF
NOTE: If a similar proposal has been reviewed and scored, but not funded, by an external funding agency, you also are invited to apply, provided your proposal meets the criteria stipulated above. In such a case, you must include a copy of the reviews (complete summary statement) as an Appendix at the end of the proposal.
Submission of full applications is by invitation only
Due Date: DEC. 20, 2016, no later than 2:00 PM
Email subject line: CTSA Pilot Studies 2017
Submit a single pdf to: CTSA-Pilot-Studies@buffalo.edu
NOTE: If a similar proposal has been reviewed and scored, but not funded, by an external funding agency, you also are invited to apply, provided your proposal meets the criteria stipulated above. In such a case, you must include a copy of the reviews (complete summary statement) as an Appendix at the end of the proposal.